Silvia de Muga
Hospital Del Mar(ES)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, PI3K/AKT/mTOR signaling in cancer, Lung Cancer Treatments and Mutations, Fibroblast Growth Factor Research
Most-Cited Works
- → FGFR3 mutations in prostate cancer: association with low-grade tumors(2009)74 cited
- → Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas(2010)69 cited
- → A 12-Gene Expression Signature Is Associated with Aggressive Histological in Prostate Cancer(2012)67 cited
- → Association of ERG and TMPRSS2‐ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels(2015)65 cited
- → Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer(2012)63 cited
- → HER2 as a target in invasive urothelial carcinoma(2015)56 cited
- → PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events(2010)51 cited
- → KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations(2008)44 cited
- → Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC(2019)35 cited
- → Assessment of ALK Status by FISH on 1000 Spanish Non-Small Cell Lung Cancer Patients(2014)29 cited